MERRIMACK PHARMACEUTICALS INC 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Mar 9, 2015
Insider Transaction Report
Form 4
Mulroy Robert J.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2015-03-05$1.71/sh+22,385$38,278→ 1,361,701 total - Exercise/Conversion
Stock Option (right to buy)
2015-03-05−22,385→ 284,368 totalExercise: $1.71Exp: 2015-08-03→ Common Stock (22,385 underlying) - Sale
Common Stock
2015-03-05$12.50/sh−22,385$279,813→ 1,339,316 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This option is fully vested.